Solorzano, Carmen C <br/><br/>
Administration of optimal biological dose and schedule of interferon alpha combined with gemcitabine induces apoptosis in tumor-associated endothelial cells and reduces growth of human pancreatic carcinoma implanted orthotopically in nude mice.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  May 2003 
 - 1858-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis--drug effects<br/>Cell Division--drug effects<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Endothelium, Vascular--metabolism<br/>Fibroblast Growth Factor 2--metabolism<br/>Humans<br/>Implants, Experimental<br/>Interferon-alpha--administration & dosage<br/>Interleukin-8--metabolism<br/>Male<br/>Matrix Metalloproteinase 9--metabolism<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Neoplasms, Experimental<br/>Pancreatic Neoplasms--drug therapy<br/>Platelet Endothelial Cell Adhesion Molecule-1--metabolism<br/>Survival Rate<br/>Tumor Cells, Cultured<br/>Vascular Endothelial Growth Factor A--metabolism<br/>Gemcitabine